Ahabir Abiraterone Acetate Tablets

Get a Price/Quote

MOQ : 10 Pieces

Ahabir Abiraterone Acetate Tablets Specification

Salt Composition
Abiraterone Acetate

Dosage Form
Tablets

Indication
Prostate Cancer

Feature
For export, high purity, prescription-only

Ingredients
Abiraterone Acetate 250 mg

Application
Oncology/Prescription Use

Physical Color/Texture
Tablet form, likely white/off-white (as seen on packaging)

Storage Instructions
Store in a cool, dry place below 30C

Shelf Life
As per expiry date on pack (typically 24-36 months)

Regulatory Status
Pharmaceutical-grade, export quality

Strength
250 mg

Prescription Requirement
Yes

Brand Name
AHABIR

Administration Route
Oral

Marketed For
Advanced prostate cancer, metastatic castration-resistant prostate cancer (mCRPC)

Packaging Size
120 Tablets per pack/box

Country of Export
Distributed to Canada, EU, UK, USA, Australia (as shown by flags on image)

Ahabir Abiraterone Acetate Tablets About

Experience the elite solution for advanced prostate cancer with AHABIR Abiraterone Acetate Tablets 250 mg. This ravishing, pharmaceutical-grade, export-quality formulation boasts masterful precision and high purity-crafted for effectiveness in metastatic castration-resistant prostate cancer (mCRPC). Supplied in a terrific 120-tablet pack for global distribution (Canada, EU, UK, USA, and Australia), AHABIR is available at a Special Rate. Prescription-required, the oral tablets feature rigorous export standards from a reputable Indian manufacturer. Secure your supply now-Get It Now for a truly unparalleled oncology treatment.

Premium Oncology Support: Prescription Excellence

Ahabir Abiraterone Acetate Tablets are expertly used for the treatment of advanced and metastatic castration-resistant prostate cancer. Targeted for prescription use only, these tablets are administered orally, ensuring a direct and efficient delivery method. The product appeals to elite healthcare professionals managing oncology patients. Designed for oncological intervention, AHABIR assures masterful quality and reliable dosage for those requiring specialized prostate cancer care.

Sample Availability & Global Supply Network

Ahabir Abiraterone Acetate Tablets come with the possibility of requesting a sample before finalizing your bulk order. The supply ability meets international standards, catering primarily to the main domestic market and supported by swift processing of purchase orders. Interested clients are encouraged to submit a purchase order to learn the current asking price and secure prompt delivery. With a robust supply chain, AHABIR is distributed across Canada, EU, UK, USA, and Australia.

FAQ's of Ahabir Abiraterone Acetate Tablets:

Q: How should AHABIR Abiraterone Acetate Tablets be administered?

A: AHABIR tablets are taken orally, typically as directed by a healthcare professional specializing in oncology. They should be swallowed whole with water and not chewed, split, or crushed.

Q: What conditions are AHABIR Abiraterone Acetate Tablets indicated for?

A: AHABIR is indicated for the treatment of advanced prostate cancer, especially metastatic castration-resistant prostate cancer (mCRPC), under proper medical supervision.

Q: When should I store AHABIR tablets for optimal effectiveness?

A: Store AHABIR tablets in a cool, dry place below 30C and away from moisture to preserve their pharmaceutical integrity until the expiry date indicated on the packaging.

Q: Where are AHABIR Abiraterone Acetate Tablets exported from and to which countries?

A: AHABIR is manufactured and supplied from India and exported to countries including Canada, the European Union, United Kingdom, USA, and Australia.

Q: What is the process to purchase AHABIR tablets for export?

A: To purchase AHABIR for export, submit a purchase order specifying quantity and destination. Once your inquiry is reviewed, you will be provided the asking price and delivery terms.

Q: What are the benefits of using AHABIR Abiraterone Acetate Tablets for cancer therapy?

A: AHABIR provides a high-purity, export-quality solution for advanced prostate cancer, contributing to effective disease management under professional medical guidance.

Tell us about your requirement